People who strongly prefer oral medication, travel frequently, or dislike injections may lean toward tablets
Chinas late-2024 tirzepatide approval and accompanying USD 1 billion local manufacturing commitment highlight strategic focus on domestic capacity that supports rapid volume ramp-up [3]National Medical Products Administration, Tirzepatide Approval for Type 2 Diabetes, nmpa.gov.cn
Cell 172:1063-1078 e1019
Many people experience nausea, vomiting, diarrhea, constipation, or stomach pain
Definition and diagnostic criteria of clinical obesity [published correction appears in Lancet Diabetes Endocrinol
K-Beauty (Korean beauty) is internationally recognised for its gentle, science-backed formulations that target specific skin concerns without compromising the skin barrier